What You Should Know:
- Foresite Capital, a San Francisco, CA-based healthcare and life sciences investment firm, announced today the successful closing of its sixth fund with a significant $900M in capital commitments. This new fund fuels Foresite's mission to invest in groundbreaking technologies across the healthcare spectrum.
- Fund VI attracted a diverse group of limited partners, including university endowments, charitable foundations, medical institutions, pension funds,
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
AlidaBio Secures $7.5M to Optimize Epitranscriptomic Research
What You Should Know:
- Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation from FusionX Ventures and Vertical Venture Partners, is complemented by two ongoing SBIR grants totaling $4 million from The National Human Genome Research Institute
Read More
DexCare Secures Strategic Investments from Tampa General, Community Health Network, Texa Health
What You Should Know:
- DexCare, Inc., a provider of care orchestration platforms for health systems, announced today the addition of three strategic investors: Community Health Network, Tampa General Hospital, and Texas Health Resources.
- These new partners join DexCare's impressive roster of existing health system investors, including Providence, Kaiser Permanente, and Mass-General Brigham.
Industry Backing Fuels Growth
This strategic investment, led by ICONIQ Growth
Read More
Omniscient Secures Series C Funding to Expand AI-Powered Brain Mapping
What You Should Know:
- Omniscient (o8t®), a Sydney, Australia-based global leader in applying AI to unlock the secrets of the human brain, announced today the successful conclusion of its Series C funding round. This round brings the company's total capital raised to US$60M , marking a significant milestone in its growth trajectory.
- The funding round highlights the confidence of prominent Australian investors, including Will Vicars and Gina Rinehart, in Omniscient's vision and
Read More
Canary Speech Secures $13M for AI-Powered Vocal Biomarkers
What You Should Know:
- Canary Speech, Inc. (Canary), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $13M Series A funding round.
- The round was led by Cortes Capital, LLC (Love’s Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.
Canary's Cutting-Edge Technology
Canary Speech leverages vocal analysis to identify early signs of mental health and neurological conditions.
Read More
Anterior Secures $20M to Streamline Healthcare Administration with GenAI
What You Should Know:
- Anterior, a healthcare administration platform built by clinicians raises $20M in Series A funding round.
- Led by New Enterprise Associates (NEA), the round included participation from Sequoia Capital, Blue Lion Global, and Neo. Formerly known as Co:Helm, Anterior recently rebranded to reflect its focus on moving healthcare administration forward.
Unburdening Clinicians with AI
Anterior's mission is to free doctors and nurses from the
Read More
Sware Secures $6M to Help Life Sciences Eliminate Validation Debt
What You Should Know
- Sware has secured $6 million in Series B funding to enhance its software validation solution for life sciences companies.
- The new funding will support research and development, AI-driven capabilities, and expansion of Sware's sales team to address validation debt.
Insights into Sware's Growth and Innovation
Sware, a leading provider of comprehensive software validation solutions for the life sciences industry, has announced a successful raise of $6 million in
Read More
Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection
What You Should Know:
- Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
- This funding, led by ARTIS Ventures, Highland Capital Partners, NTTVC, and Questa Capital, will fuel Eko's mission to expand access to its innovative platform in the U.S. and globally.
Building on a Strong Foundation of Innovation and Clinical Validation
This funding round comes on the heels of
Read More
Nucleus RadioPharma Secures Investment from AstraZeneca
What You Should Know:
- Nucleus RadioPharma, the world's first comprehensive radiopharmaceutical organization, today announced the closing of an extended Series A funding round with the addition of new investor AstraZeneca.
- The strategic investment bolsters Nucleus' mission to make targeted radiotherapies and theranostics more accessible to patients worldwide.
AstraZeneca Joins Forces with Leading Radiopharmaceutical Innovator
AstraZeneca joins a distinguished group of
Read More
Sword Health Secures $130M, Unveils AI Care Specialist “Phoenix”
What You Should Know:
- Sword Health, a pioneer in AI-powered healthcare delivery, announced a $130M financing round today bringing Sword's total funding to $340M and propelling the company's valuation to a staggering $3B– a 50% increase since its Series D round.
- This funding round, coupled with Sword's near-tripled revenue growth in the past year, unlocks exciting possibilities for the future. The company plans to leverage these resources to revolutionize healthcare delivery and
Read More
